Brian Nowosielski

Look back at some of the amazing insights during McKesson ideaShare, the premier event for community pharmacists.

Researchers compared health care and prescription medication affordability during the COVID-19 pandemic to pre-pandemic numbers.

Farron Dozier, former sergeant first class in the US Army, sat down with Drug Topics on a recent episode of Over the Counter to discuss his experience with PTSD.

Check out this recap of articles published on our sister sites during the past week.

Researchers aimed to address the extent of stigmatization’s effect on the mental health of adolescents with chronic skin disorders.

“They may not understand. But I tell people, ‘I don't want you to understand me.’ I don't understand me. But if you can relate to me, then that furthers our conversation—the relatedness,” said Farron Dozier on his experience with PTSD.

A former sergeant first class in the US Army discussed PTSD in an exclusive interview with Drug Topics.

Emily Flaugher, Vice President and General Manager of Health Mart Atlas and Atlas Specialty at McKesson, sat down with Drug Topics to discuss McKesson solutions that help independent pharmacists maximize reimbursement.

The FTC released its interim report detailing PBM practices, staggering market consolidation statistics, and the disparities between PBMs and their smaller competitors.

Researchers addressed the association between semaglutide use and the risk of nonarteritic anterior ischemic optic neuropathy.

Jeremy Cundiff, PharmD, co-owner of Professional Pharmacy Group, joined Drug Topics to discuss Return Solutions and the company’s Rx Returns process.

Drug Topics sat down with Sandra Canally, RN, founder and CEO of The Compliance Team, and Kara Benson, PharmD, long-term care director of Lewis Drug Inc, to discuss the future of LTC pharmacy.

Drug Topics has been on site at McKesson ideaShare this week! Check out this podcast to hear a few of the things we've experienced and what we've learned so far.

At McKesson ideaShare 2024, Andrea Sikora discussed artificial intelligence and how it has gradually been integrated into health care systems.

Don’t miss out on the latest pharmacy insights in the Total Pharmacy June issue.

Drug Topics has been on site at McKesson ideaShare this week. Check out this podcast to hear a few of the exciting happenings at this year’s meeting.

See what’s trending in pharmacy with a preview of the Total Pharmacy June issue.

Check out this recap of articles published on our sister sites during the past week.

In a webinar conducted by the National Foundation for Infectious Diseases (NFID), experts gathered to publicly address the ongoing bird flu outbreak across many US states.

Medication nonadherence can account for up to 50% of treatment failures and over $500 billion in annual health care costs.

In 2 abstracts presented at ASCO 2024, researchers addressed the use of GLP-1s for weight loss and to reduce cardiovascular outcomes in women with breast cancer.

From the Health Mart Pharmacy of the Year award presentation to general sessions covering pharmacy profitability, community impact, and much more, see what’s to come at this year’s meeting in New Orleans.

In a session presented at the 2024 Heart in Diabetes Conference, Neha Pagidipati, MD, MPH, discussed weight change and its effects on cardiovascular complications.

Nicolette Mathey, PharmD, founder of ATRIUM24 and Dotti CRM, discussed how new technological tools can help pharmacists care for more patients.

Check out this recap of articles published on our sister sites during the past week.

In abstracts presented at the 2024 American Society of Clinical Oncology’s annual meeting, researchers addressed the association between heart failure and multiple types of cancers.

In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.

The Supreme Court ruled on the question of limiting access to to mifepristone, a key abortion drug that anti-abortion groups have been working to limit across the country.

The APhA urged policy makers to consider these recommendations to avoid further exacerbating effects of the attack on US health systems.

CDC researchers reported on the improvements and inaccuracies of assays within the Vitamin D Standardization-Certification Program.